| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $7K | -37.2% | -96.8% |
| SG&A Expense | $928K | +47.7% | -44.9% |
| Operating Income | -$935K | -46.3% | +50.6% |
| Pre-tax Income | -$971K | -43.8% | +48.8% |
| Income Tax | -$10.6M | — | — |
| Net Income | -$1.2M | -15.5% | +55.3% |
| EPS (Basic) | -$0.75 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.5M | — | +586.3% |
| Accounts Receivable | $37K | — | — |
| Current Assets | $87.7M | +5.3% | +4.6% |
| Total Assets | $135.4M | +59.1% | +57.7% |
| Current Liabilities | $33.5M | +12.9% | +113.6% |
| Total Liabilities | $45.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.7M | — | — |
| Investing Cash Flow | $336K | — | — |
| Financing Cash Flow | $3.7M | — | — |
| -27.1% |
| EPS (Diluted) | -$0.75 | -257.1% | -27.1% |
| +54.4% |
| +190.5% |
| Stockholders' Equity | $27.9M | +542.7% | +233.1% |